Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival.

导出 OA

翻译打印收藏纠错

第一作者： Gaëlle,Müller-Greven

第一单位： Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio.

作者： Gaëlle,Müller-Greven ^[1] ; Cathleen R,Carlin ^[2] ; Monica E,Burgett ^[3] ; Manmeet S,Ahluwalia ^[1] ; Adam,Lauko ^[2] ; Amy S,Nowacki ^[4] ; Cameron J,Herting ^[1] ; Maha A,Qadan ^[5] ; Markus,Bredel ^[6] ; Steven A,Toms ^[1] ; Justin D,Lathia ^[2] ; Dolores,Hambardzumyan ^[7] ; Jann N,Sarkaria ^[8] ; Petra,Hamerlik ^[4] ; Candece L,Gladson ^[9]

作者单位： Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. ^[1] School of Biomedical Sciences, Kent State University, Kent, Ohio. ^[2] Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio. ^[3] Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. ^[4] Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio. ^[5] Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. ^[6] Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama. ^[7] Department of Neurosurgery, Geisinger Medical Center, Geisinger, Pennsylvania. ^[8] Department of Cell and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. ^[9] Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. ^[10] Brain Tumor Biology, Danish Cancer Society Research Center, Copenhagen, Denmark. ^[11] Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. gladsoc@ccf.org. ^[12]